WELCOME BACK: Drugmakers’ top lobbying group is welcoming lawmakers back to town this week with a seven-figure ad blitz, ramping up pressure on Congress to enact a crackdown on pharmaceutical ...

Across the recent three months, 33 analysts have shared their insights on NVIDIA NVDA, expressing a variety of opinions ...

Intel faces challenges after losing its Dow Jones spot to Nvidia. Federal aid under the CHIPS Act could bolster US ...